Pfizer, Wyeth Post Lackluster Sales as They Prepare for a Future Together
Executive Summary
Pfizer's new business units - which are key to transforming the company - came under Wall Street scrutiny as the company for the first time broke down first quarter sales per unit in an earnings report released April 28
You may also be interested in...
Health Care Reform For Pfizer Equals $800 Million Revenue Hit In 2012
The addition of legacy Wyeth products helped cushion Pfizer's top-line in the first quarter, and synergies stemming from the integration could help the company absorb the cost of health care reform
Health Care Reform For Pfizer Equals $800 Million Revenue Hit In 2012
The addition of legacy Wyeth products helped cushion Pfizer's top-line in the first quarter, and synergies stemming from the integration could help the company absorb the cost of health care reform
Health Care Reform For Pfizer Equals $800 Million Revenue Hit In 2012
Pfizer maintained its 2012 earnings per share guidance, despite the lower revenue projections, however.